News

Trusted TIPS device is the first approved to offer a 6-10 mm diameter range, delivering greater control to physicians treating portal hypertension.

Putzbrunn, Germany (JULY 9, 2025) — W. L. Gore & Associates (Gore) announces CE Mark approval of an expanded indication for the GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) when used as a bridging stent with branched and fenestrated aortic endografts^† in the treatment of aortic aneurysms involving the renal and mesenteric arteries.

PUTZBRUNN, Germany (January 13, 2025) — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. Medical Products (Gore) announced recent CE mark of a lower profile GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft).

PUTZBRUNN, Germany (February 1, 2024) — W. L. Gore & Associates, Inc. (Gore) today announced the first ever implantation of the GORE^® TAG^® Thoracic Branch Endoprosthesis (TBE) in Europe. The patient was treated by Prof. Dittmar Boeckler, Chief of the Department of Vascular Surgery and Endovascular Surgery at University Hospital Heidelberg, Germany.

This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this condition.

Putzbrunn, GERMANY (16 February, 2023) — W. L. Gore & Associates, Inc. (Gore) announced that it is initiating the EMBRACE Registry to capture real-world data about the GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) used as a bridging stent in conjunction with a branched/fenestrated stent graft.

This registry will confirm safety and performance of the VBX Stent Graft in peripheral vessels in patients who require interventional treatment in a variety of applications and diseases.